Cellectar Biosciences INC NEW (CLRB) is a publicly traded Healthcare sector company. As of May 21, 2026, CLRB trades at $3.08 with a market cap of $25.09M and a P/E ratio of -0.38. CLRB moved +0.00% today. Year to date, CLRB is -5.37%; over the trailing twelve months it is -59.97%. Its 52-week range spans $2.43 to $67.50. Analyst consensus is strong buy with an average price target of $10.33. Rallies surfaces CLRB's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for CLRB combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $3.08 |
| Market Cap | $25.09M |
| P/E Ratio | -0.38 |
| EPS | $-8.35 |
| Dividend Yield | 0.00% |
| 52-Week High | $67.50 |
| 52-Week Low | $2.43 |
| Volume | 7.38K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-21.79M |
| Gross Margin | 0.00% |
3 analysts cover CLRB: 0 strong buy, 3 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $10.33.